Huron Consulting Group Inc. (HURN) - Q3 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2025. Huron Consulting Group Inc. is a global professional services firm operating in three segments: Healthcare, Education, and Commercial. The company delivers services through two principal capabilities: Consulting and Managed Services and Digital. During the quarter, Huron completed several strategic acquisitions, including Eclipse Insights, Treliant, and Wilson Perumal & Company (WP&C), to expand its revenue cycle, financial services, and strategy offerings.
Key Financial Metrics
| Metric | Q3 2025 | Q3 2024 | YTD 9M 2025 | YTD 9M 2024 |
|---|---|---|---|---|
| Total Revenues | $441.3 million | $378.1 million | $1,257.2 million | $1,122.5 million |
| Revenues (Excl. Reimbursable) | $432.4 million | $370.0 million | $1,230.6 million | $1,097.7 million |
| Operating Income | $50.0 million | $42.4 million | $128.4 million | $121.8 million |
| Net Income | $30.4 million | $27.1 million | $74.4 million | $82.6 million |
| Diluted EPS | $1.71 | $1.47 | $4.13 | $4.43 |
| Adjusted EBITDA | $67.4 million | $54.9 million | $169.5 million | $144.4 million |
| Cash & Equivalents | $23.9 million | $21.9 million (Dec '24) | N/A | |
| Total Debt Outstanding | $611.0 million | $357.7 million (Dec '24) | N/A | |
| Operating Cash Flow (9M) | N/A | $67.0 million | $61.7 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenues before reimbursable expenses increased 16.8% in Q3 2025 compared to Q3 2024. Organic growth was 10.2%, excluding $28.3 million from acquisitions and the impact of the Studer Education divestiture.
- Segment Performance:
- Healthcare: Revenues up 19.9%; Operating income up 36.5% to $67.8 million.
- Education: Revenues up 6.9%; Operating income up 14.0% to $33.2 million.
- Commercial: Revenues up 26.6% (driven by acquisitions); Operating income decreased 15.4% to $13.7 million due to integration costs and higher compensation expenses.
- Profitability: Net income increased 12.0% in Q3, but decreased 10.0% on a year-to-date basis. The YTD decrease was primarily driven by a $15.0 million litigation settlement gain recognized in Q2 2024 and a $11.1 million non-cash credit impairment charge on a convertible debt investment in Q2 2025.
- Debt Structure: In July 2025, the company amended its credit facility, establishing a $700 million Revolver and a $400 million Term Loan. Total borrowings increased to $611.0 million to fund acquisitions and operations.
Guidance, Outlook, and Risks
- Acquisition Activity: The company continues its programmatic acquisition strategy. Five acquisitions were completed in the first nine months of 2025, with aggregate consideration of $151.6 million. Preliminary valuations for Treliant and WP&C remain subject to change.
- Capital Allocation: The company repurchased 1,084,794 shares for $152.5 million in the first nine months of 2025. As of September 30, 2025, $112.6 million remains available under the $700 million share repurchase program authorized through December 2026.
- Investment Impairments: Significant non-cash charges impacted YTD results, including an $11.1 million credit-related impairment on the Shorelight Holdings convertible debt investment and $5.0 million in impairments on a hospital-at-home equity investment.
- Restructuring: Restructuring charges were $3.5 million in Q3 2025, primarily related to office space exits (Pensacola, FL) and severance.
- Risk Factors: Key risks include the ability to integrate acquired businesses, fluctuations in utilization rates, dependence on client renewals, and exposure to interest rate and foreign currency fluctuations.
Investor Verification Checklist
- Acquisition Valuations: Verify the final purchase price allocations for Treliant and WP&C, as current goodwill and intangible asset values are preliminary.
- Investment Fair Value: Monitor the fair value of the Shorelight Holdings convertible debt investment ($32.8 million) and the hospital-at-home equity investment ($2.4 million) for further impairment risks.
- Debt Covenants: Confirm continued compliance with the Consolidated Leverage Ratio (currently 2.30x) and Interest Coverage Ratio (currently 8.86x) under the new Amended Credit Agreement.
- Commercial Segment Margins: Assess the trajectory of the Commercial segment's operating margin, which declined to 16.4% in Q3 2025 from 24.5% in Q3 2024 due to integration costs.
- Organic Growth Sustainability: Evaluate whether the 10.2% organic revenue growth in Q3 is sustainable given the high acquisition contribution ($28.3 million) in the same period.